All news articles for August 2013

Who's Bought Who in the Late Summer Sales

Who's Bought Who in the Late Summer Sales

By Dan Stanton

Amgen spent $10.4bn (€7.8bn) this week on Onyx Pharmaceuticals, but AstraZeneca and Johnson & Johnson have also opened up their wallets this week – welcome to in-Pharmatechnologist.com’s merger & acquisition round-up.

Siegfried Sees 1H Profits Rise

Siegfried Sees 1H Profits Rise on APIs, Orders and Acquisitions

Swiss API manufacturer Siegfried reported that higher API sales and custom synthesis orders drove a profit increase in the first half of the year and predicted that recent capacity hike and new China plant would help maintain positive momentum.

Amgen Acquires Onyx for $10.4bn

Amgen Acquires Onyx for $10.4bn

Amgen has spent $10.4bn (€7.8bn) in acquiring Onyx Pharmaceuticals saying its oncology products and pipeline will be strengthened by Amgen’s manufacturing capabilities.